RET-Positive Metastatic NSCLC
Playback speed
10 seconds
ESMO 2022 on the Results of the Randomized DICIPLE Phase 3 Trial: Nivo + Ipi 6-Month Treatment vs. Continuation in Advanced NSCLC
By
ESMO 2022 Conference Coverage
FEATURING
Gerard Zalcman
By
ESMO 2022 Conference Coverage
FEATURING
Gerard Zalcman
1,092 views
September 15, 2022
Login to view comments.
Click here to Login